Constantin Tuleasca
Overview
Explore the profile of Constantin Tuleasca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peters D, Conti A, Levivier M, Schiappacasse L, Faouzi M, Trandafirescu M, et al.
Brain Spine
. 2025 Feb;
5:104184.
PMID: 39935528
Introduction: Cystic brain metastases (BMs) are often more challenging to treat than solid BMs. Stereotactic cyst aspiration for volume reduction followed by stereotactic radiosurgery (SRS) is an alternative treatment modality...
2.
Bourhila C, Cotrutz C, Conti A, Schiappacasse L, Levivier M, Tuleasca C
J Clin Neurosci
. 2025 Jan;
133:111043.
PMID: 39793312
Introduction: Stereotactic radiosurgery (SRS) is one of the treatment options for the management of residual or recurrent secreting pituitary adenomas (PA). While the role of radiosurgery (RS) by Gamma Knife...
3.
Cotrutz C, Levivier M, Tuleasca C
Phys Med
. 2024 Sep;
126:104820.
PMID: 39341175
Background: Recent studies suggest strong correlations between Biologically Effective Doses (BED) and single fraction stereotactic radiosurgery treatment outcomes, as demonstrated for vestibular schwannomas (VS), arterio-venous malformations and pituitary adenomas. The...
4.
Bourhila C, Cotrutz C, Daniel R, George M, Schiappacasse L, Patin D, et al.
Acta Neurochir (Wien)
. 2024 Aug;
166(1):348.
PMID: 39177697
Background: Stereotactic radiosurgery (SRS) represents a minimally invasive and valuable alternative for jugular foramen schwannomas (JFS), both as upfront and/or adjuvant treatment (in hybrid approaches). Methods: We conducted a retrospective...
5.
Bourhila C, Levivier M, Tuleasca C
N Engl J Med
. 2024 Jun;
390(21):2036.
PMID: 38838325
No abstract available.
6.
Kinj R, Hottinger A, Bohlen T, Ozsahin M, Vallet V, Dunet V, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730695
Purpose: to evaluate an SRT approach in patients with at least 10 lesions at the time of BM initial diagnosis. Methods: This is a monocentric prospective cohort of patients treated...
7.
Lawson McLean A, Vetrano I, Lawson McLean A, Conti A, Mertens P, Muther M, et al.
Brain Spine
. 2024 Apr;
4:102794.
PMID: 38601776
Introduction: The field of neurosurgery faces challenges with the increasing involvement of other medical specialties in areas traditionally led by neurosurgeons. This paper examines the implications of this development for...
8.
Peters D, Tuleasca C, Giammattei L, Starnoni D, Daniel R
J Neurosurg
. 2024 Feb;
140(6):1818-1820.
PMID: 38394659
No abstract available.
9.
Dynamic functional changes upon thalamotomy in essential tremor depend on baseline brain morphometry
Bolton T, Van De Ville D, Regis J, Witjas T, Girard N, Levivier M, et al.
Sci Rep
. 2024 Jan;
14(1):2605.
PMID: 38297028
Patients with drug-resistant essential tremor (ET) may undergo Gamma Knife stereotactic radiosurgical thalamotomy (SRS-T), where the ventro-intermediate nucleus of the thalamus (Vim) is lesioned by focused beams of gamma radiations...
10.
Tuleasca C, Carey G, Barriol R, Touzet G, Dubus F, Luc D, et al.
Neurosurg Rev
. 2024 Jan;
47(1):73.
PMID: 38296852
Stereotactic radiosurgery (SRS) is one of the surgical alternatives for drug-resistant essential tremor (ET). Here, we aimed at evaluating whether biologically effective dose (BED) is relevant for tremor improvement after...